PURE

PURE Bioscience

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/14/2016
Contact Info
  • 1725 Gillespie Way
  • El Cajon, CA 92020

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jul 31, 2016 10-K
CIK 0001006028
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2890 - Miscellaneous Chemical Products
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 1992
Employees 13 a/o Oct 24, 2013
Company Officers/Contacts
Henry Lambert CEO
Mark Elliott VP, Fin., Principal Fin. Officer, Principal Acct. Officer
Company Directors
David Pfanzelter Chairman
Gary D. Cohee
Tom Y. Lee
William Otis
David Theno
Company Notes
  • Formerly=Innovative Medical Services until 10-03
Service Providers
Accounting/Auditing Firm
Mayer Hoffman McCann P.C.
10616 Scripps Summit Court
San Diego, CA, 92131
United States

Legal Counsel
DLA Piper LLP
4365 Executive Drive
Suite 1100
San Diego, CA, 92101-4297
United States

Investor Relations Firm
Bibicoff & MacInnis, Inc.
18801 Ventura Blvd.
Suite 312
Tarzana, CA, 91356
United States

PURE Security Details
Share Structure
Market Value1 $62,551,839 a/o Dec 02, 2016
Authorized Shares 100,000,000 a/o Nov 07, 2014
Outstanding Shares 64,823,917 a/o Oct 27, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Transfer Online, Inc.
Shareholders
Shareholders of Record 227 a/o Oct 27, 2016
Short Selling Data
Short Interest 33,407 (3.81%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security